Friday, November 4, 2016 Daily Archives

Enzo Life Sciences Launches New PLAQPROâ„¢ Lp-PLA2 Assay to Measure Cardiac Risk

Enzo Life Sciences is proud to introduce our new assay, PLAQPROâ„¢ Lp-PLA2 Assay, measuring the activity of Lp-PLA2 in vitro.  Lp-PLA2 is produced by inflammatory cells and circulates primarily bound to LDL. The oxidization of LDL is an early key event in the pathogenesis of atherosclerosis. Increased levels of Lp-PLA2 have been found in atherosclerotic plaques and rupture lesions. The PLAQPROâ„¢ Lp-PLA2 Assay is a colorimetric readout assay that measures the activity of Lp-PLA2 in serum samples. Our assay represents a cost-efficient alternative to…

Enzo Life Sciences Launches New Immunoassay to Detect Low Levels of IL-6

Enzo Life Sciences is proud to introduce our newest immunoassay, IL-6 (human), high sensitivity ELISA kit, the most sensitive IL-6 ELISA on the market. Enzo’s new kit is able to detect IL-6 levels down to 0.057 pg/mL. In addition, our kit offers detection in 3 hours, with liquid color-coded reagents that reduce the possibility for error. From forty years of manufacturing, Enzo’s immunoassays offer high precision, accuracy, sensitivity, and specificity. IL-6 is a cytokine critical to the regulation of the…